Literature DB >> 1571425

Persistent infection with Chlamydia pneumoniae following acute respiratory illness.

M R Hammerschlag1, K Chirgwin, P M Roblin, M Gelling, W Dumornay, L Mandel, P Smith, J Schachter.   

Abstract

Chlamydia pneumoniae is emerging as a significant cause of respiratory disease, including pneumonia and bronchitis, in humans. In this recently completed study of infection due to C. pneumoniae in patients presenting with pneumonia to SUNY Health Science Center at Brooklyn, we identified two individuals for whom cultures were positive on multiple occasions over a 1-year period. To determine the frequency of persistent respiratory infection with C. pneumoniae, follow-up specimens were obtained from nine individuals with culture-documented C. pneumoniae infection. Five of these individuals had persistent infection: four had a flulike illness characterized by pharyngitis, and one had bronchitis with prominent bronchospasm. All five individuals appeared to have acute C. pneumoniae infection as determined by results of serologic tests (titers of IgM antibody for all individuals were greater than or equal to 1:16). For three patients, cultures remained positive for 11 months despite therapy with 10- to 21-day courses of tetracycline or doxycycline. These observations suggest that persistent infection with C. pneumoniae may follow acute infection and may persist for many months. Infection with C. pneumoniae may be very difficult to eradicate with use of currently available antibiotics even if there is a clinical response to therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1571425     DOI: 10.1093/clinids/14.1.178

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  71 in total

Review 1.  Molecular diagnosis of Chlamydia pneumoniae infection.

Authors:  J Boman; C A Gaydos; T C Quinn
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 3.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model.

Authors:  A Kutlin; C Flegg; D Stenzel; T Reznik; P M Roblin; S Mathews; P Timms; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells.

Authors:  Robert E Molestina; Jon B Klein; Richard D Miller; William H Pierce; Julio A Ramirez; James T Summersgill
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

6.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

8.  Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays.

Authors:  Petra Apfalter; Wolfgang Barousch; Marion Nehr; Athanasios Makristathis; Birgit Willinger; Manfred Rotter; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 9.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae.

Authors:  Jens Gieffers; Jan Rupp; Andreas Gebert; Werner Solbach; Matthias Klinger
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.